Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Impossible Foods Seeks to Sell Plant-Based Burgers in Europe

Published 10/23/2019, 07:42 AM
Updated 10/23/2019, 08:46 AM
© Reuters.  Impossible Foods Seeks to Sell Plant-Based Burgers in Europe

(Bloomberg) -- Impossible Foods Inc. has applied to start selling its plant-based burgers in the European Union as it looks to expand outside the U.S. and Asia.

The maker of the Impossible Burger filed an application to market soy leghemoglobin, the iron-containing molecule made with a genetically engineered yeast, according to the EU’s food safety authority. The ingredient, known as heme, is a key additive for helping replicate the richness of meat flavors.

Genetically-modified foods and labeling are tightly regulated in the EU, unlike the U.S., which could mean approval could take time. If it gets the green light, the Impossible Burger will join an increasingly crowded market for faux meat in Europe. Beyond Burger has already made inroads in supermarkets on this side of the Atlantic, and is featured at racing-driver Lewis Hamilton’s new plant-based burger chain.

Nestle SA (SIX:NESN), the world’s biggest food company, has also just accelerated efforts to tap demand for faux meat. The Swiss firm recently rolled out a plant-based burger in the U.S., but had previously been focusing on its Garden Gourmet vegetarian products, including the Incredible Burger, in Europe.

Demand has boomed as consumers seek out foods they see as healthier and more environmentally friendly than beef. Imitation meat could reach 9% of the estimated $2.7 trillion global meat market by 2040, Jefferies analyst Simon Powell forecasts, from less than 1% now.

The EU application from Impossible Foods was filed Sept. 30 with the Dutch government under the EU’s regulation on genetically modified food and feed, and passed onto the European Food Safety Authority, filings show.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

(Updates with context on EU regulation and details on food market in third paragraph.)

Latest comments

It had a medicine drug flavor when I ate it.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.